Enalapril " Convertin ' :
Trade names: Enalaprilat, Convertin
Drug classes
· Antihypertensive
· ACE inhibitor
Pregnancy: (Category C/ D if used in the 2nd or 3rd trimesters.]
Therapeutic actions
Renin, synthesized by the kidneys, is released into the circulation where it acts on a plasma precursor to produce angiotensin I, which is converted by angiotensin-converting enzyme to angiotensin II, a potent vasoconstrictor that also causes release of aldosterone from the adrenals; both of these actions increase BP. Enalapril blocks the conversion of angiotensin I to angiotensin II, decreasing BP, decreasing aldosterone secretion, slightly increasing serum K+ levels, and causing Na+ and fluid loss; increased prostaglandin synthesis also may be involved in the antihypertensive action.
Indications
- Treatment of hypertension alone or in combination with thiazide-type diuretics
- Treatment of acute and chronic CHF
- Treatment of asymptomatic left ventricular dysfunction (LVD)
- Treatment of acute hypertension--IV
Contraindications/cautions
- Contraindication: allergy to enalapril.
- Use cautiously with impaired renal function; salt/volume depletion--hypotension may occur; lactation
Dose
§ Hypertension, used alone, initially 5 mg once daily;
§ if used in addition to diuretic, in elderly patients, or in renal impairment, initially 2.5 mg daily;
§ Usual maintenance dose 10–20 mg once daily;
§ In severe hypertension may be increased to max. 40 mg once daily
§ Heart failure (adjunct), asymptomatic left ventricular dysfunction, initially 2.5 mg daily under close medical supervision; usual maintenance dose 20 mg daily in 1–2 divided doses
Adverse effects
- CNS: Headache, dizziness, fatigue, insomnia, paresthesias
- GI: Gastric irritation, nausea, vomiting, diarrhea, abdominal pain, dyspepsia, elevated liver enzymes
- CV: Syncope, chest pain, palpitations, hypotension in salt/volume depleted patients
- Hematologic: Decreased hematocrit and hemoglobin
- GU: Proteinuria, renal insufficiency, renal failure, polyuria, oliguria, urinary frequency, impotence
- Other: Cough, muscle cramps, hyperhidrosis
Clinically important interactions
- Drug-drug
- Decreased hypotensive effect if taken concurrently with indomethacin, rifampin
Nursing Considerations
- If pt undergoes any types of surgery alert surgeon and mark patient's chart with notice that enalapril is being taken; the angiotensin II formation subsequent to compensatory renin release during surgery will be blocked; hypotension may be reversed with volume expansion.
- Monitor patients on diuretic therapy for excessive hypotension following the first few doses of enalapril.
- Monitor patient closely in any situation that may lead to a fall in BP secondary to reduced fluid volume (excessive perspiration and dehydration, vomiting, diarrhea) because excessive hypotension may occur.
- Arrange for reduced dosage in patients with impaired renal function.
Monitor patient carefully because peak effect may not be seen for 4 h. Do not administer second dose until checking BP.